UNSPSC 51191571: Zidapamide

This classification denotes a diuretic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F7KU1MIY58. European Medicines Agency schedules Zidapamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00151MIG. Zidapamide generally arises in the molecular formula C16H16CLN3O3S.

UNSPSC 51191571 Zidapamide is a Commodity code that encompasses pharmaceutical active ingredients and chemical compounds used in state and local government operations, though recent solicitations under this code show limited direct activity specific to zidapamide itself. The code captures specialty chemicals and pharmaceutical products procured by municipalities and state agencies for water treatment, healthcare, and operational purposes. Issuing bodies soliciting under related pharmaceutical and chemical commodity codes include municipal water authorities, state departments of administration overseeing cooperative purchasing networks, and healthcare-adjacent government facilities. The City of Meriden's recent chemical procurement and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) pharmaceutical RFP demonstrate the range of issuing bodies active in this space — from individual municipalities managing utility operations to multi-state cooperative purchasing vehicles coordinating larger pharmaceutical supply agreements.

Recent activity spans Connecticut and Minnesota, with MMCAP's cooperative model extending purchasing authority across participating state and local government entities including Oregon. The City of Meriden posted solicitation B027-15 on July 8, 2026, for sodium bisulfite chemical supply to its Water Pollution Control Facility, with bids due July 29, 2026, under an IFB structure requiring general liability and performance bonding. MMCAP issued an RFP (S1070000015802) on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline, establishing multiple contracts for distribution across participating state and local government facilities. Successful vendors on the MMCAP agreement must supply through three authorized wholesalers, maintain cGMP and DSCSA compliance, and accept a 3 percent administrative fee, with awards effective July 1, 2026. The code shows modest recent activity; no solicitation explicitly names zidapamide, and the available opportunities reflect broader pharmaceutical and chemical supply work rather than this specific active ingredient.